CureVac fails in pivotal COVID-19 vaccine trial
2 years ago
801
German biotech CureVac NV said on Wednesday its COVID-19 vaccine was only 47% effective in a late-stage trial, missing the study's main goal and throwing in doubt the potential delivery of hundreds of millions of doses to the European Union. Emer McCarthy reports.
Loading 4 comments...
-
2:30
Reuters
8 hours agoIsrael, Iran both muted in response to Isfahan attack
386 -
1:55
KGTV
3 years agoCarlsbad 12-year-old joins COVID-19 vaccine trial
695 -
0:20
WFTX
3 years agoNew COVID-19 vaccine clinical trial
228 -
2:09
KSHB
3 years agoCMH begins child COVID-19 vaccine trial
1321 -
2:06
KJRH
2 years ago11-year-old Tulsa girl taking part in Moderna COVID-19 vaccine trial
1326 -
1:57
KNXV
2 years agoNew COVID-19 vaccine trial underway in Arizona for adolescents
45 -
2:08
WCPO
3 years agoLocal COVID-19 vaccine trial recipient speaks out
311 -
1:37
WXYZ
3 years agoCOVID-19 Vaccine Trial
4.71K2 -
2:35
KGTV
3 years agoModerna begins COVID-19 vaccine trial on minors
4653 -
1:19
Reuters
3 years agoOxford pauses UK trial of COVID-19 vaccine on kids
3744
